{"content": "The isolation of the mouse Brca1 homologue will facilitate the creation of mouse models for germline BRCA1 defects ", "annotation": [{"label": ["B-Disease"], "points": [{"text": "BRCA1", "start": 101, "end": 105}]}, {"label": ["I-Disease"], "points": [{"text": "defects", "start": 107, "end": 113}]}]}
{"content": "", "annotation": []}
{"content": "Emerin deficiency at the nuclear membrane in patients with Emery - Dreifuss muscular dystrophy ", "annotation": [{"label": ["B-Disease"], "points": [{"text": "Emerin", "start": 0, "end": 5}]}, {"label": ["B-Disease"], "points": [{"text": "Emery", "start": 59, "end": 63}]}, {"label": ["I-Disease"], "points": [{"text": "deficiency", "start": 7, "end": 16}]}, {"label": ["I-Disease"], "points": [{"text": "-", "start": 65, "end": 65}]}, {"label": ["I-Disease"], "points": [{"text": "Dreifuss", "start": 67, "end": 74}]}, {"label": ["I-Disease"], "points": [{"text": "muscular", "start": 76, "end": 83}]}, {"label": ["I-Disease"], "points": [{"text": "dystrophy", "start": 85, "end": 93}]}]}
{"content": "Mutations in the STA gene at the Xq28 locus have been found in patients with X - linked Emery - Dreifuss muscular dystrophy ( EDMD ) ", "annotation": [{"label": ["B-Disease"], "points": [{"text": "X", "start": 77, "end": 77}]}, {"label": ["B-Disease"], "points": [{"text": "EDMD", "start": 126, "end": 129}]}, {"label": ["I-Disease"], "points": [{"text": "-", "start": 79, "end": 79}, {"start": 94, "end": 94, "text": "-"}]}, {"label": ["I-Disease"], "points": [{"text": "linked", "start": 81, "end": 86}]}, {"label": ["I-Disease"], "points": [{"text": "Emery", "start": 88, "end": 92}]}, {"label": ["I-Disease"], "points": [{"text": "Dreifuss", "start": 96, "end": 103}]}, {"label": ["I-Disease"], "points": [{"text": "muscular", "start": 105, "end": 112}]}, {"label": ["I-Disease"], "points": [{"text": "dystrophy", "start": 114, "end": 122}]}]}
{"content": "This gene encodes a hitherto unknown protein named emerin ", "annotation": []}
{"content": "To elucidate the subcellular localization of emerin , we raised two antisera against synthetic peptide fragments predicted from emerin cDNA ", "annotation": []}
{"content": "Using both antisera , we found positive nuclear membrane staining in skeletal , cardiac and smooth muscles in the normal controls and in patients with neuromuscular diseases other than EDMD ", "annotation": [{"label": ["B-Disease"], "points": [{"text": "neuromuscular", "start": 151, "end": 163}]}, {"label": ["B-Disease"], "points": [{"text": "EDMD", "start": 185, "end": 188}]}, {"label": ["I-Disease"], "points": [{"text": "diseases", "start": 165, "end": 172}]}]}
{"content": "In contrast , a deficiency in immunofluorescent staining of skeletal and cardiac muscle from EDMD patients was observed ", "annotation": [{"label": ["B-Disease"], "points": [{"text": "EDMD", "start": 93, "end": 96}]}]}
{"content": "A 34 kD protein is immunoreactive with the antisera - - the protein is equivalent to that predicted for emerin ", "annotation": []}
{"content": "Together , our findings suggest the specific deficiency of emerin in the nuclear membrane of muscle cells in patients with EDMD ", "annotation": [{"label": ["B-Disease"], "points": [{"text": "deficiency", "start": 45, "end": 54}]}, {"label": ["B-Disease"], "points": [{"text": "EDMD", "start": 123, "end": 126}]}, {"label": ["I-Disease"], "points": [{"text": "of", "start": 56, "end": 57}]}, {"label": ["I-Disease"], "points": [{"text": "emerin", "start": 59, "end": 64}]}]}
{"content": "", "annotation": []}
{"content": "Growth retardation and tumour inhibition by BRCA1 ", "annotation": [{"label": ["B-Disease"], "points": [{"text": "Growth", "start": 0, "end": 5}]}, {"label": ["B-Disease"], "points": [{"text": "tumour", "start": 23, "end": 28}]}, {"label": ["I-Disease"], "points": [{"text": "retardation", "start": 7, "end": 17}]}]}
{"content": "Inherited mutations in BRCA1 predispose to breast and ovarian cancer , but the role of BRCA1 in sporadic breast and ovarian cancer has previously been elusive ", "annotation": [{"label": ["B-Disease"], "points": [{"text": "breast", "start": 43, "end": 48}, {"start": 105, "end": 110, "text": "breast"}]}, {"label": ["I-Disease"], "points": [{"text": "and", "start": 50, "end": 52}, {"start": 112, "end": 114, "text": "and"}]}, {"label": ["I-Disease"], "points": [{"text": "ovarian", "start": 54, "end": 60}, {"start": 116, "end": 122, "text": "ovarian"}]}, {"label": ["I-Disease"], "points": [{"text": "cancer", "start": 62, "end": 67}, {"start": 124, "end": 129, "text": "cancer"}]}]}
{"content": "Here , we show that retroviral transfer of the wild - type BRCA1 gene inhibits growth in vitro of all breast and ovarian cancer cell lines tested , but not colon or lung cancer cells or fibroblasts ", "annotation": [{"label": ["B-Disease"], "points": [{"text": "breast", "start": 102, "end": 107}]}, {"label": ["B-Disease"], "points": [{"text": "colon", "start": 156, "end": 160}]}, {"label": ["I-Disease"], "points": [{"text": "and", "start": 109, "end": 111}]}, {"label": ["I-Disease"], "points": [{"text": "ovarian", "start": 113, "end": 119}]}, {"label": ["I-Disease"], "points": [{"text": "cancer", "start": 121, "end": 126}, {"start": 170, "end": 175, "text": "cancer"}]}, {"label": ["I-Disease"], "points": [{"text": "or", "start": 162, "end": 163}]}, {"label": ["I-Disease"], "points": [{"text": "lung", "start": 165, "end": 168}]}]}
{"content": "Mutant BRCA1 has no effect on growth of breast cancer cells ; ovarian cancer cell growth is not affected by BRCA1 mutations in the 5 portion of the gene , but is inhibited by 3 BRCA1 mutations ", "annotation": [{"label": ["B-Disease"], "points": [{"text": "breast", "start": 40, "end": 45}]}, {"label": ["B-Disease"], "points": [{"text": "ovarian", "start": 62, "end": 68}]}, {"label": ["I-Disease"], "points": [{"text": "cancer", "start": 47, "end": 52}, {"start": 70, "end": 75, "text": "cancer"}]}]}
{"content": "Development of MCF - 7 tumours in nude mice is inhibited when MCF - 7 cells are transfected with wild - type , but not mutant , BRCA1 ", "annotation": [{"label": ["B-Disease"], "points": [{"text": "MCF", "start": 15, "end": 17}]}, {"label": ["I-Disease"], "points": [{"text": "-", "start": 19, "end": 19}]}, {"label": ["I-Disease"], "points": [{"text": "7", "start": 21, "end": 21}]}, {"label": ["I-Disease"], "points": [{"text": "tumours", "start": 23, "end": 29}]}]}
{"content": "Most importantly , among mice with established MCF - 7 tumours , peritoneal treatment with a retroviral vector expressing wild - type BRCA1 significantly inhibits tumour growth and increased survival ", "annotation": [{"label": ["B-Disease"], "points": [{"text": "MCF", "start": 47, "end": 49}]}, {"label": ["B-Disease"], "points": [{"text": "tumour", "start": 163, "end": 168}]}, {"label": ["I-Disease"], "points": [{"text": "-", "start": 51, "end": 51}]}, {"label": ["I-Disease"], "points": [{"text": "7", "start": 53, "end": 53}]}, {"label": ["I-Disease"], "points": [{"text": "tumours", "start": 55, "end": 61}]}]}
{"content": "", "annotation": []}
